Physician profile
John Victor Kaspar
NPI 1891786091
$1,122,833.44
in general payments reported to CMS, 2019-2025
50 companies · $82K in 2025
The $82K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174K · 2020: $155K · 2021: $218K · 2022: $247K · 2023: $173K · 2024: $74K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $245K · Consulting Fee: $49K · Travel and Lodging: $19K · Food and Beverage: $16K · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $244,943.75 |
| Consulting Fee | $49,439.00 |
| Travel and Lodging | $18,613.95 |
| Food and Beverage | $15,943.13 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $780,672.22 | 2020-2025 | Urolift, Barrigel |
| Neotract INC. | $300,628.07 | 2019-2020 | |
| Astellas Pharma US INC | $9,865.91 | 2019-2023 | Myrbetriq |
| Axonics, INC. | $8,064.48 | 2020-2024 | Axonics, Bulkamid |
| Dendreon Pharmaceuticals LLC | $7,117.25 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $4,025.51 | 2023-2025 | Gemtesa, Orgovyx |
| Srs Medical Systems, INC. | $2,776.02 | 2020-2022 | |
| Olympus America INC. | $2,438.46 | 2021-2025 | Itind System, Bovie, Oes Cystonephrofiberscope |
| Procept Biorobotics Corporation | $1,239.65 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Medtronic, INC. | $724.59 | 2025 | Altaviva |
| Olympus Corporation of The Americas | $647.50 | 2022 | |
| Janssen Biotech, INC. | $485.33 | 2019-2025 | Erleada |
| Abbvie INC. | $446.81 | 2019-2025 | |
| Boston Scientific Corporation | $410.91 | 2019-2025 | Axonics, Bulkamid |
| Myriad Genetic Laboratories, INC. | $389.70 | 2021-2024 | Prolaris |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $283.87 | 2019-2024 | |
| Accord Healthcare, INC. | $238.32 | 2022 | |
| Urovant Sciences INC | $223.58 | 2021-2022 | |
| Antares Pharma, INC. | $182.02 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Endo Pharmaceuticals INC. | $181.37 | 2019-2023 | Xiaflex |
| Allergan, INC. | $163.89 | 2019-2022 | |
| Valencia Technologies Corporation | $157.44 | 2022 | |
| Urogen Pharma, INC. | $140.53 | 2021-2024 | Jelmyto |
| Ferring Pharmaceuticals INC. | $134.86 | 2019-2025 | Adstiladrin |
| Pfizer INC. | $132.75 | 2019-2025 | |
| Medtronic USA, INC. | $102.68 | 2019 | |
| Acerus Pharmaceuticals Corporation | $85.40 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.43 | 2020-2025 | |
| Tolmar Pharmaceuticals, INC. | $83.27 | 2019-2022 | |
| Amgen INC. | $74.98 | 2019-2021 | |
| Endo USA, INC. | $57.63 | 2024-2025 | Xiaflex |
| Laborie Medical Technologies Corp. | $52.82 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $47.49 | 2023-2024 | Lynparza, Keytruda, Welireg |
| Arrow International, INC. | $46.66 | 2022 | |
| Clarus Therapeutics INC. | $43.17 | 2021 | |
| Progenics Pharmaceuticals, INC. | $41.54 | 2024-2025 | |
| Immunitybio, INC. | $41.16 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Alnylam Pharmaceuticals INC. | $32.72 | 2025 | Givlaari |
| Travere Therapeutics, INC. | $32.53 | 2020-2021 | |
| Myovant Sciences INC. | $32.27 | 2021-2022 | |
| Tolmar, INC. | $26.93 | 2023 | |
| Ambu INC. | $24.71 | 2020 | |
| Baxter Healthcare | $19.98 | 2021 | |
| Halozyme INC | $17.80 | 2023 | |
| Baudax Bio INC. | $17.56 | 2020 | |
| Novo Nordisk INC | $17.46 | 2024 | Rivfloza |
| Telix Pharmaceuticals | $16.17 | 2022 | |
| Coloplast Corp | $14.08 | 2021 | |
| Mission Pharmacal Company | $13.90 | 2023 | Uribel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kaspar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.